New Blood Test for Alzheimer’s Disease
Dr. Jeremy Koppel recently discussed a significant breakthrough involving a blood test designed to identify Alzheimer’s disease risk. This test detects abnormal protein build-up, providing insights into its current role in diagnosing symptomatic individuals.
Early Signs of Alzheimer’s Disease
A recent Finnish study highlights how certain medical conditions may indicate early-onset Alzheimer’s disease years before an official diagnosis. The research shows that conditions like depression, vertigo, and headaches often occur more frequently in the years leading up to an Alzheimer’s diagnosis.
The study involved analyzing medical records of 407 individuals with early-onset Alzheimer’s and 4,035 without the diagnosis over a period of 15 years prior to the diagnosis.
Research Findings
Findings revealed that the following conditions were more common in individuals eventually diagnosed with early-onset Alzheimer’s:
- Vertigo: 5.9% in diagnosed individuals, versus 2.1% in those undiagnosed
- Depression: 5.7% versus 2.3%
- Headache: 4.9% versus 1.6%
- Stroke: 4.4% versus 2.0%
- Alcohol-related disorders: 3.4% versus 1.4%
- Brain disorders: 2.9% versus 0.9%
- Thyroid disorders: 2.5% versus 0.8%
- Epilepsy: 2.2% versus 0.7%
- Delirium: 1.5% versus 0.1%
- Ear, nose, and throat disorders: 5.2% versus 2.9%
Implications for Diagnosis
The study also discovered increased healthcare visits among early-onset Alzheimer’s patients around the time of diagnosis. This pattern might suggest the onset of symptoms.
Suvi-Johanna Krüger, M.D., Ph.D., weighed in, noting that Alzheimer’s neuropathological changes start long before symptoms arise.
Study Limitations
This observational study highlights correlations but doesn’t prove these conditions predict Alzheimer’s. Possible reasons for these associations include genetics, lifestyle, or socioeconomic factors affecting outcomes. Further research may determine if these medical conditions can improve early Alzheimer’s detection.
Early diagnosis is crucial since it enables access to more treatment options and support services in the disease’s early stages. This preemptive approach benefits both the individuals and their families by allowing future planning.
Leave a Reply